Search results
Showing 7486 to 7500 of 8219 results
Discontinued Reference number: GID-SGWAVE0700
Discontinued Reference number: GID-IP1156
In development Reference number: GID-TA11585 Expected publication date: TBC
In development Reference number: GID-TA11607 Expected publication date: 13 January 2027
In development Reference number: GID-TA11166 Expected publication date: TBC
Concizumab for treating haemophilia A or B in people 12 years and over with inhibitors [ID6665]
In development Reference number: GID-TA11888 Expected publication date: TBC
In development Reference number: GID-TA11556 Expected publication date: TBC
Mozafancogene autotemcel for treating Fanconi anaemia in people 1 to 17 years [ID12203]
In development Reference number: GID-TA11781 Expected publication date: TBC
In development Reference number: GID-TA11441 Expected publication date: TBC
Etripamil for treating paroxysmal supraventricular tachycardia [ID6581]
In development Reference number: GID-TA11750 Expected publication date: TBC
Asthma: diagnosis, monitoring and chronic asthma management (NG80)
This guideline has been updated and replaced by NICE guideline NG245.
VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions (DG19)
We have moved Diagnostics guidance 19 to become HealthTech guidance 388. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
SepsiTest assay for rapidly identifying bloodstream bacteria and fungi (DG20)
We have moved Diagnostics guidance 20 to become HealthTech guidance 400. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
We have moved Diagnostics guidance 22 to become HealthTech guidance 401. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
We have moved Diagnostics guidance 24 to become HealthTech guidance 413. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.